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Permissive Secondary Mutations
Enable the Evolution of Influenza
Oseltamivir Resistance
Jesse D. Bloom, Lizhi Ian Gong, David Baltimore*
The His274→Tyr274 (H274Y) mutation confers oseltamivir resistance on N1 influenza neuraminidase
but had long been thought to compromise viral fitness. However, beginning in 2007–2008, viruses
containing H274Y rapidly became predominant among human seasonal H1N1 isolates. We show that
H274Y decreases the amount of neuraminidase that reaches the cell surface and that this defect can
be counteracted by secondary mutations that also restore viral fitness. Two such mutations occurred
in seasonal H1N1 shortly before the widespread appearance of H274Y. The evolution of oseltamivir
resistance was therefore enabled by “permissive”mutations that allowed the virus to tolerate subsequent
occurrences of H274Y. An understanding of this process may provide a basis for predicting the
evolution of oseltamivir resistance in other influenza strains.
Influenza A is a respiratory virus that causesannual epidemics and occasional pandemics,of which the worst on record killed in excess of 20 million people worldwide (1). One of themain defenses against influenza is the antiviraldrug oseltamivir (Tamiflu, F. Hoffmann-La Roche,
Incorporated) (2), and over 200 million doses
have been stockpiled worldwide (3). Oseltamivir
binds in the active site of the neuraminidase
(NA) enzyme expressed on the virion surface,
preventing it from cleaving sialic acid moieties
that can be bound by the viral hemagglutinin
protein (2). This lack of NA activity inhibits the
release of newly formed virions from infected
cells (4), as well as causing viral aggregation (4),
reducing infectivity (5, 6), and limiting the
ability of viruses to penetrate mucus found in
the airways (6).
During clinical testing of oseltamivir, a small
fraction of human participants who were infected
with the seasonal human H1N1 influenza strain
A/Texas/36/1991 (TX91) and then treated with
oseltamivir eventually shed resistant viruses (7).
These viruses carried a mutation of histidine to
tyrosine at NA residue 274 (H274Y), which is
found near but not directly in the substrate-
binding pocket (8). This mutation causes subtle
structural alterations that weaken oseltamivir
binding (8, 9). However, TX91 viruses with H274Y
were attenuated in tissue culture, mice, and fer-
rets (10). H274Y also impaired the growth of the
H1N1 lab strain A/WSN/33 (WSN) in tissue cul-
ture (11) and the infectivity of the seasonal H1N1
strain A/New Caledonia/20/1999 (NC99) in fer-
rets (12). These studies led to the conclusion that
“[v]irus carrying a H274Y mutation is unlikely to
be of clinical consequence (10).”
This conclusion held sway from the intro-
duction of oseltamivir as a drug in 1999 until the
2007–2008 influenza season, when oseltamivir-
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Fig. 1. H274Y decreases NA surface expression and viral fitness for H1N1 lab
strains. (A) Plasmids encoding wild-type (WT, black squares) or H274Y (gray circles)
NAs were transfected into 293T cells. Cells were assayed for total surface NA activity
in a nonlysing buffer. (B) The same cells were assayed by flow cytometry for mean
surface NA expression using a monoclonal antibody against the PR8 tetramer. (C) Surface activity of WT, H274Y, or H274Y-R194G WSN NA at 18 hours. All four
graphs show mean T SEM for at least three independent transfections. (D) An estimated 50 infectious particles of each color of WSN-PB1flank-eGFP and/or
mCherry carrying the indicated NA mutations were infected into 2.5 × 105 A549-CMV-PB1 cells. After 46 to 50 hours, the cells were analyzed by flow cytometry
to quantify virus growth. Numbers give percentages of cells in each gate; one representative plot is shown for each virus pair. (E) Relative fitness (ratio of
Malthusian growth parameters) with respect to WT calculated from at least eight replicates. Shown are geometric means and 95% confidence intervals.




































resistant H274Y seasonal H1N1 viruses ap-
peared worldwide (13). Within a year, H274Y
was present in most seasonal H1N1 (13). These
viruses showed no obvious attenuation relative
to earlier viruses carrying tyrosine at position 274
(14).
We hypothesized that the evolution of oseltamivir
resistance was enabled by permissive mutations
that alleviated the deleterious effects of subse-
quent occurrences of H274Y. Earlier studies have
failed to find large effects of H274Y on substrate
affinity or catalytic rate in otherwise isogenic NAs
(9–11). We therefore further hypothesized that
these permissive mutations buffered previously
unobserved deficiencies in NA folding or stabil-
ity caused by H274Y. This hypothesis was mo-
tivated by the observation that functionally
adaptive mutations often come at a cost to pro-
tein stability or folding and that mutations that
bolster these properties can therefore promote
evolvability (15).
Preliminary experiments uncovered no obvi-
ous differences in the stabilities of wild-type and
H274Y NAs to irreversible thermal denaturation
(fig. S1), so we examined whether H274Y
hampered the efficiency with which folded NA
reached the cell surface. Plasmids encoding wild-
type or H274Y NA were transfected into 293T
Fig. 2. Total surface-expressed activity for WT
(black squares) and H274Y (gray circles) NAs from
(A) three seasonal human H1N1 strains and (B)
the pandemic swine-origin A/California/4/2009
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Fig. 3. Identification of mutations that buffer defects in NA surface expression and viral
fitness caused by H274Y in seasonal human H1N1. (A) Maximum-likelihood
phylogenetic tree showing NC99 and all seasonal H1N1 strains from 2006 or later.
Based on a maximum-likelihood reconstruction, branches with H274Y are colored red,
whereas those without are colored black. Indicated are the first five mutations on the
path from NC99 to the large group of H274Y viruses. Bootstrap percentages are shown
for key nodes. Branches with V234M are shaded dark blue, and those with both V234M
and R222Q are shaded light blue. One of the isolated H274Y sequences contained an
independent appearance of V234M as indicated. The NC99 and SI06 sequences are
labeled. (B) Surface-expressed activity at 20 hours for NC99 NAs with sequential
addition of the five reconstructed mutations, both with and without H274Y. (C) Surface-
expressed activity and mean staining intensity at 20 hours for NC99 NAs containing a
C-terminal epitope tag. (D) An estimated 50 infectious particles of PB1flank-eGFP with the
indicated NC99 NAs and the remaining genes from TX91 were infected into 2.5 × 105
MDCK-SIAT1-CMV-PB1 cells, and the viral titer in the supernatent was determined at the
indicated times. All graphs show mean T SEM for at least three replicates.




































cells, and the total NA activity expressed on the
cell surface was measured by using a fluoro-
genic substrate (16). Cells transfected with wild-
type NA expressed at least twofold more total
surface activity than those transfected with
H274Y, both for NAs from WSN and from
another H1N1 lab strain, A/PR/8/34 (PR8) (Fig.
1A). Previous studies found little effect of
H274Yon the catalytic activity per unit enzyme
(9–11), suggesting that the differences are due
to fewer NAs at the cell surface. To test this, we
used a monoclonal antibody to quantify the
amount of PR8 NA on the surface of transfected
cells (Fig. 1B). Surface expression closely cor-
responded to total surface activity, confirming that
H274Y decreases the amount of NA that is inserted
into the membrane.
An evolutionarily important feature of muta-
tions that interfere with protein folding is that
they can frequently be compensated for by other
mutations at sites distant in the three-dimensional
structure (17, 18). We used a computational meth-
od (19) to predict that Arg194→Gly194 (R194G),
which occurs over 20 Å from H274Y in the
folded structure (fig. S2), might have this com-
pensatory effect on WSN NA. Introducing
R194G into H274Y WSN NA restored the total
surface-expressed activity to about wild-type levels
(Fig. 1C).
To examine whether a mutation that restored
NA surface expression would also restore viral
fitness, we created WSN viruses possessing PB1
segments in which most of the coding sequence
was replaced by a gene encoding either an
enhanced green or a red fluorescent protein
(eGFP or mCherry) (fig. S3). Because these
segments retained the noncoding and 80 terminal
coding nucleotides, they were packaged effi-
ciently and stably into virions (20, 21) (fig. S3).
These PB1flank-eGFP/mCherry viruses grew to
high titers in cells constitutively expressing the
PB1 protein. We created variants of both colors
carrying wild-type, H274Y, or H274Y-R194G
NAs and performed viral growth assays by
adding about 50 infectious particles of each color
to 2.5 × 105 A549 human lung carcinoma cells
that expressed PB1 protein. After 46 to 50 hours,
flow cytometry was used to quantify the cells
infected by each color virus (Fig. 1D). WSN
viruses with H274Y were strongly attenuated
relative to wild type (Fig. 1E), in agreement with
earlier work (11). However, H274Y virus also
carrying R194G exhibited fitness indistinguish-
able from that of the wild type (Fig. 1E).
The foregoing results indicate that the defect
caused by H274Y can be corrected by secondary
mutations. To determine whether this actually
occurred in human influenza, we examined NAs
from seasonal H1N1. Introducing H274Y into
TX91 and NC99 NAs caused an ~twofold de-
crease in total surface expressed activity (Fig.
2A); earlier studies have shown that H274Y at-
tenuates these strains in ferrets (10, 12). But
H274Y caused a much smaller decrease in the
more recent A/Solomon Islands/3/2006 (SI06)
strain (Fig. 2A). We built a phylogenetic tree
incorporating NC99 and all seasonal H1N1 NAs
from 2006 or later (Fig. 3A) and traced along this
tree from NC99 toward the large group of
H274Y viruses, sequentially adding the first five
reconstructed mutations in the order which max-
imum likelihood suggested that they occurred.
Two of the reconstructed mutations had impor-
tant effects on total surface-expressed NA activity
(Fig. 3B). The first, Val234→Met234 (V234M)
(which is found in SI06), decreased the magnitude
of the defect caused by H274Y. The second,
Arg222→Gln222 (R222Q), increased total surface-
expressed activity for NAs both with and without
H274Y. Both of these mutations were retained in
all members of the large group of H274Y se-
quences (Fig. 3A). Neither mutation is in close
contact with H274 in the folded NA structure
(fig. S2).
To confirm that V234M and R222Q increase
the amount of NA that reaches the cell surface,
we added a C-terminal epitope tag. This tag was
readily stained by fluorescent antibodies and did
not substantially interfere with NA folding or
function, because it caused at most a slight
(<10%) decrease in total surface-expressed ac-
tivity (Fig. 3C). Both V234M and R222Q in-
creased the amount of NA that reached the cell
surface; the activity per enzyme was unaffected
by V234M and slightly decreased by R222Q
(Fig. 3C). The NC99 NA carrying R222Q and
V234M in addition to H274Y expressed a total
surface activity roughly equivalent to that of wild
type.
We next constructed PB1flank-eGFP viruses
carrying NC99 NAs with the relevant mutations.
The non-NA segments for these viruses were
derived from the closely related (>98% protein
identity) TX91 strain. We engineered a cell line
(MDCK-SIAT1) that expresses high levels of the
sialic acid linkage preferred by human influenza
(22) to also constitutively express PB1 protein.
We infected 2.5 × 105 cells with an estimated 50
infectious particles and monitored viral growth.
The H274Y virus was strongly attenuated,
growing to ~100-fold lower titers than wild type
(Fig. 3D). However, virus carrying H274Y in
conjunction with R222Q and V234M grew to
levels comparable to that of wild type, as did
virus carrying just R222Q and V234M (Fig. 3D).
In the presence of 250 nM oseltamivir, only vi-
ruses carrying H274Y grew to substantial titers,
with the H274Y-R222Q-V234M triple mutant
growing to over 100-fold higher titers than virus
with H274Y alone (Fig. 3D). Therefore, by ac-
cumulating the permissive V234M and R222Q
mutations and then acquiring H274Y, NC99 vi-
rus can become resistant to oseltamivir while
maintaining high levels of fitness in the absence
of drug.
It is interesting to speculate about what drove
the spread of these mutations in seasonal H1N1.
The permissive mutations could be the result of
stochastic drift, genetic hitchhiking (23), or se-
lection for antigenic change or tuning of the
NA/hemagglutinin balance (24). Once the per-
missive mutations were in place, H274Y could
have been the product of any of these same forces
or of direct selection for oseltamivir resistance. The
fact that initial geographic prevalence of H274Y
was not correlated with oseltamivir usage is gen-
erally viewed as evidence against direct selection
for resistance (25), although the lack of persistent
spatial structure in human influenza (26, 27) makes
it difficult to ascribe selection pressures to specific
geographic locations.
Regardless of the forces that eventually drove
its spread, our results show that H274Yattenuates
seasonal H1N1 unless there are permissive sec-
ondary mutations that maintain adequate surface
NA expression. These mutations likely buffer
defects in NA folding or transport that are caused
by H274Y. The reduced fitness of H274Yviruses
in the absence of such permissivemutations could
be caused by insufficient NA to balance the re-
ceptor binding of hemagglutinin (24) or to stim-
ulate proper virion assembly (28).
The evolution of H274Y in seasonal H1N1
adds to a growing collection of examples of the
importance of permissive mutations in molecular
evolution. These examples include the evolution
of bacterial antibiotic resistance (29, 30), the
escape of HIV from cytotoxic T lymphocytes (31),
and the acquisition of new ligand specificity in
vertebrate steroid receptors (32). An appealing
aspect of our findings is that, in addition to elucidat-
ing the historic role of permissive mutations, they
may also provide a basis for making informed
predictions. The pandemic swine-origin 2009
A(H1N1) viruses that recently swept the globe
remainmostly oseltamivir-sensitive, but scattered
H274Y isolates have emerged (33). It remains
unclear whether these isolates are less-fit evolu-
tionary dead ends or harbingers of a resistance mu-
tation that will soon spread worldwide. Introducing
H274Y into the swine-origin A/California/4/2009
NA causes a large drop in total surface-expressed
activity (Fig. 2B). We therefore suggest that, un-
less these swine-origin viruses already express
substantial excess NA, the long-term evolution-
ary potential of H274Y isolates might depend
on secondary mutations that rescue NA sur-
face expression.
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The Incidence of Fire in Amazonian
Forests with Implications for REDD
Luiz E. O. C. Aragão1*† and Yosio E. Shimabukuro2*
Reducing emissions from deforestation and degradation (REDD) may curb carbon emissions,
but the consequences for fire hazard are poorly understood. By analyzing satellite-derived
deforestation and fire data from the Brazilian Amazon, we show that fire occurrence has
increased in 59% of the area that has experienced reduced deforestation rates. Differences
in fire frequencies across two land-use gradients reveal that fire-free land-management can
substantially reduce fire incidence by as much as 69%. If sustainable fire-free land-management
of deforested areas is not adopted in the REDD mechanism, then the carbon savings achieved
by avoiding deforestation may be partially negated by increased emissions from fires.
Reducing emissions from deforestation anddegradation (REDD) is one of the mostcost-effective mitigation mechanisms (1)
and could contribute to an emission reduction of
13 to 50 billion tons of carbon (Gt C) by 2100
(2). REDD is therefore a high-priority mecha-
nism for mitigation of climate change within the
United Nations Framework Convention on Cli-
mate Change (UNFCCC). The future of REDD
implementation relies on forthcoming agreements
to tackle the unresolved outcomes from the 15th
Convention of the Parties, which took place in
December 2009. These negotiations can largely
influence the maintenance or replacement of the
Kyoto Protocol beyond 2012 and the future of
tropical forests. Policy-makers are considering a
range of options for developing countries to re-
ceive financial incentives to reduce their de-
forestation rates (2). However, the efficacy of
REDD as a climate change mitigation strategy
depends, in particular, upon the stabilization of
deforestation and degradation of the world’s largest
rainforest, the Amazon.
Deforestation in the Brazilian Amazon (defined
as clear cutting and conversion of the original
forest cover to other land uses) has resulted in
annual forest area loss of 18,918 T 1,576 km2
(SEM) from 1998 to 2007, according to the
National Institute for Space Research (INPE) in
Brazil (3). It is estimated that this results in
release of 0.28 (0.17 to 0.49) Gt C to the atmo-
sphere annually (4), corresponding to 24% of the
world’s C emissions from land cover change
[1.15 (0.58-1.79) Gt C year−1] (5). In principle,
discontinuing ongoing deforestation through
mechanisms such as REDD would protect a large
fraction of the 86 Gt of the carbon stored in
Amazonian forest biomass (6), which is equiv-
alent to about a decade of global fossil fuel emis-
sions to the atmosphere. However, there is a
pressing need to consider the threat to forests
posed by fire.
Fires following drought years are likely to
release a similar amount of carbon as emissions
from deliberate deforestation (7, 8). The com-
bined effect of deliberate deforestation and forest
fires has a similar magnitude to the natural annual
carbon sink of 0.45 (0.3 to 0.6) Gt C estimated
for undisturbed Amazonian forests (9). The high-
er probability of a drier Amazon in the 21st
century predicted by some global circulation
models (10, 11), and consequent increasing
drought intensity and frequency, may push Am-
azonia toward an amplified fire-prone system
(12). Previous studies (13, 14) have shown an
increase in fire occurrence following two large-
scaleAmazoniandroughts (1998and2005).Changes
in fire frequency could jeopardize the benefits
achieved through REDD; however, despite its
vital importance in this region, fire is currently
neglected in the emerging UN framework.
Operational satellite-derived deforestation (3)
and fire (15) data sets produced by INPE, and
land cover information from the European Com-
mission’s Joint Research Centre (16), provide a
unique opportunity to quantify the sensitivity of
fires to changes in deforestation rates and land
use in the Brazilian Amazon. Fire in the Brazilian
Amazon is likely to follow three plausible path-
ways: (i) Fire incidence may decrease with reduced
deforestation rates by restraining human activities
that are major ignition sources (8, 13, 14, 17). (ii)
It may increase even with reduced deforesta-
tion rates, both through slashing and burning of
secondary forests (18) in already deforested
areas that are not monitored by INPE’s Program
for Deforestation Assessment in the Brazilian
Legal Amazonia (PRODES) (19) and through
continuous enlargement of forest edges (20) and
increasing area of secondary forest cover (21)
that are more susceptible to fire (22). (iii) Fire
incidence may decrease because of a shift
from extensive (unmanaged) to intensive (man-
aged) land-use methods, as the latter is normal-
ly not accompanied by deliberate use of fire
(23).
To distinguish the first two pathways we used
all available regionwide data from INPE to per-
form a pixel-based analysis of temporal trends in
deforestation rates and fire incidence (19). For
each pixel at 0.25° by 0.25° (or 774.35 km2)
spatial resolution, the annual fraction deforested
for the period from 2000 to 2007 was derived by
aggregating the 60-m spatial resolution pixels
from INPE’s PRODES annual deforestation maps
(3, 19). Similarly, the annual number of fires for
each 0.25° by 0.25° pixel for the period from 1998
to 2006 was derived (19) by aggregating the daily
1Landscape and Ecosystems Dynamics Group, School of Ge-
ography, University of Exeter, Amory Building, Rennes Drive,
Exeter, Devon, EX4 4RJ, UK. 2Remote Sensing Division,
National Institute for Space Research, Avenida dos Astronautas,
12227–010, São José dos Campos, São Paulo, Brazil.
*These authors contributed equally to this work.
†To whom correspondence and requests for materials should
be addressed. E-mail: l.aragao@exeter.ac.uk.
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compensate for the deleterious effect of H274Y and restore fitness to the virus.
neuraminidase enzyme. In the more vigorous recent oseltamivir-resistant isolates, other mutations 
) show that the H274Y mutation hinders the folding of theHolmessee the Perspective by 
 (p. 1272;et al.Bloom seasonal influenza. So what happened that improved viral fitness so radically? 
grew poorly, but by 2008 the virus was reinvigorated and the mutation had spread worldwide in
the 274 residue (H274Y) of neuraminidase. When the resistant virus was first discovered in 1998, it 
resistance has emerged in seasonal strains mediated by a single point mutation of histidine to tyrosine in
a dangerous influenza pandemic. So far, its large-scale use has not been required, but, despite this, 
Tamiflu, or oseltamivir, has been extensively stockpiled by several governments in anticipation of
Influenza Escape Tricks
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